TKADLEC, Jan, Vaclav CAPEK, Marie BRAJEROVA, Eva SMELIKOVA, Oto MELTER, Tamara BERGEROVA, Sylvia POLIVKOVA, Magda BALEJOVA, Marketa HANSLIANOVA, Daniela FACKOVA, Katerina NERADOVA, Renata TEJKALOVÁ, Iva VAGNEROVA, Natasa BARTONIKOVA, Eva CHMELAROVA, Pavel DREVINEK a Marcela KRUTOVA. The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic. Journal of Antimicrobial Chemotherapy. OXFORD: Oxford University Press, 2021, roč. 76, č. 1, s. 55-64. ISSN 0305-7453. Dostupné z: https://dx.doi.org/10.1093/jac/dkaa404.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic
Autoři TKADLEC, Jan (203 Česká republika, garant), Vaclav CAPEK (203 Česká republika), Marie BRAJEROVA (203 Česká republika), Eva SMELIKOVA (203 Česká republika), Oto MELTER (203 Česká republika), Tamara BERGEROVA (203 Česká republika), Sylvia POLIVKOVA (203 Česká republika), Magda BALEJOVA (203 Česká republika), Marketa HANSLIANOVA (203 Česká republika), Daniela FACKOVA (203 Česká republika), Katerina NERADOVA (203 Česká republika), Renata TEJKALOVÁ (203 Česká republika, domácí), Iva VAGNEROVA (203 Česká republika), Natasa BARTONIKOVA (203 Česká republika), Eva CHMELAROVA (203 Česká republika), Pavel DREVINEK (203 Česká republika) a Marcela KRUTOVA (203 Česká republika).
Vydání Journal of Antimicrobial Chemotherapy, OXFORD, Oxford University Press, 2021, 0305-7453.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10606 Microbiology
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.758
Kód RIV RIV/00216224:14110/21:00121695
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1093/jac/dkaa404
UT WoS 000620811500006
Klíčová slova anglicky molecular epidemiology; methicillin-resistant Staphylococcus aureus
Štítky 14110113, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 2. 6. 2021 13:23.
Anotace
Objectives: To gain data on the current molecular epidemiology and resistance of MRSA in the Czech Republic. Methods: Between September 2017 and January 2018, a total of 441 single-patient MRSA isolates were collected from 11 Czech hospitals and analysed by spa typing, SCCmec typing, antibiotic susceptibility testing, detection of the PVL toxin and the arcA gene. Results: Of all MRSA isolates, 81.41% (n = 359) belonged to the CC5-MRSA clone represented by the spa types t003 (n = 136), t586 (n = 92), t014 (n = 81), t002 (n = 20) and other spa types (n = 30); a majority of the CC5 isolates (n = 348, 96.94%) carried SCCmec type II. The occurrence of CC5-MRSA was more Likely in older inpatients and associated with a healthcare origin (P< 0.001). The CC5-MRSA isolates were resistant to more antimicrobial drugs compared with the other MRSAs (P< 0.001). Interestingly, t586 was detected in blood samples more often than the other spa types and, contrary to other spa types belonging to CC5-MRSA, t586 was not associated with patients of advanced age. Other frequently found Lineages were CC8 (n = 17), CC398 (n = 11) and CC59 (n = 10). The presence of the PVL was detected in 8.62% (n = 38) of the MRSA isolates. Conclusions: The healthcare-associated CC5-MRSA-II Lineage (t003, t586, t014) was found to be predominant in the Czech Republic. t586 is a newly emerging spa type in the Czech Republic, yet reported rarely in other countries. Our observations stress the need for MRSA surveillance in the Czech Republic in order to monitor changes in MRSA epidemiology.
VytisknoutZobrazeno: 9. 8. 2024 07:41